Between the Biotech Waves cover image

Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse

Between the Biotech Waves

CHAPTER

The Path to Financing in 2023

Do you have a sense of companies that may have gone at last year that were actually unable to finance and you know is do you think that people in 23 may be more receptive to those companies again. Yeah I think we've seen something very similar to the private market right and where people you know companies went out for a second quarter in 2022 to raise but they weren't successful. And then on the situation there's always a platform technology that is so exciting and so disruptive and is well credentialed with a managed team and existing investors that provide a foundational base that those opportunities can still get funded in the public markets. The IPO market currently is not is not really conditioned for that type of opportunity.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner